Discover BAROSTIM NEO™
CVRx® developed a proprietary implantable technology for the treatment of heart failure and high blood pressure. BAROSTIM NEO™ uses CVRx-patented technology that is designed to trigger the body’s own natural blood flow regulation system to treat these conditions. BAROSTIM NEO™ can be adjusted to meet each patient’s individual therapy needs.Learn More
Follow CVRx in the News
- See the 6 month data from the BeAT Heart Failure Study presented 9 May 2019 at HRS and 27 May 2019 at ESC-HF.
- CVRx® Announces First Two Patients Treated in Pivotal Trial Evaluating BAROSTIM THERAPY™ for the Treatment of Heart Failure
- CVRx® Announces Expedited Access Pathway Designation by FDA for BAROSTIM THERAPY™
- Heart Failure Clinical Trial Results Presented at ESC-Heart Failure 2015 Annual Conference